Medicine guide
Mvabea
·
- Prescription status not stated
- Antibiotics, antivirals and antifungals taken into the body
- Active substance
- Ebola vaccine (MVA-BN-Filo [recombinant])
- Made by
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
- Mvabea, as part of the Zabdeno, Mvabea vaccine regimen, is indicated for active immunisation for prevention of disease caused by Ebola virus (Zaire ebolavirus species) in individuals ≥ 1 year of age (see sections 4.4 and 5.1).
From the official label · 2026-09-30 · European Medicines Agency
Details
| Made by | |
|---|---|
| Active substance | Ebola vaccine (MVA-BN-Filo [recombinant]) |
| Used in | Antibiotics, antivirals and antifungals taken into the body |
| Classification | J07BX · Antibiotics, antivirals and antifungals taken into the body |
| Additional monitoring ▼ | Yes — under additional monitoring (black triangle). Report suspected side effects. |
| Authorised on | 2020-07-01 |
| Last updated by the regulator | 2026-05-05 |
| EMA product number | EMEA/H/C/005343 |
Source: European Medicines Agency — medicine data · 2026-09-30 · not reviewed by a clinician
Source: European Medicines Agency (EMA). Product information as published by EMA. Reuse terms: EMA legal notice (reproduction authorised).